文献速递咽喉与嗓音

同种异体脂肪基质注射声带填充术的前瞻性短期结局

Prospective Short-Term Outcomes of Allograft Adipose Matrix (AAM) for Vocal Fold Augmentation.
PubMed 文献 · Laryngoscope · 2025-11-06

这项前瞻性临床试验纳入16例单侧声带麻痹患者,采用同种异体脂肪基质(AAM)行注射喉成形术。结论认为AAM短期安全有效,但需更长随访。

要点

  • AAM注射喉成形术在单侧声带麻痹患者中短期安全,无不良反应报告。
  • 3个月时81.3%病例嗓音改善,CAPE-V平均降低32.3分,VHI-10平均降低11.3分。

核心结论

  • AAM作为单侧声带麻痹注射填充材料在早期随访中安全有效。

研究设计与样本

  • 前瞻性临床试验,共21例患者接受AAM注射,其中16例单侧声带麻痹患者纳入分析。
  • 采用盲法独立喉科医生和专家听评者,在治疗前和注射后3个月进行视频喉镜和CAPE-V评估。

主要发现

  • 无不良反应发生。
  • 评估者观察到81.3%的病例治疗后嗓音改善。
  • CAPE-V评分平均降低32.3分(p < 0.01)。
  • VHI-10评分平均降低11.3分(p = 0.02)。

关键数值与推荐

  • 嗓音改善率81.3%,CAPE-V平均降低32.3分(p < 0.01),VHI-10平均降低11.3分(p = 0.02)。

临床怎么用

  • AAM可作为单侧声带麻痹注射喉成形术的短期填充材料,需告知患者长期疗效尚待验证。

局限性

  • 随访时间仅3个月,样本量较小(16例分析),需更长随访研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Injection laryngoplasty is a common procedure to improve glottic closure following unilateral vocal fold paralysis (UVFP) or vocal fold atrophy. Allograft adipose matrix (AAM, Renuva, MTF Biologics) supports neoadipogenesis making it a potentially permanent solution. Given the known favorable properties of vocal fold lipoinjection, we hypothesize AAM to be a useful injection material with possible durable results following injection laryngoplasty. MATERIALS AND METHODS: A prospective clinical trial of patients with UVFP underwent injection augmentation laryngoplasty with AAM. Blinded independent laryngologists and expert listeners used pretreatment and 3-month postinjection videostroboscopy and CAPE-V assessments to evaluate glottic closure, pliability and voice quality changes. Patient-reported outcome measures (PROMs) were evaluated. RESULTS: A total of 21 patients underwent AAM injection; 16 had a diagnosis of unilateral vocal fold paralysis and were included for analysis. There were no adverse reactions. The raters observed an improvement in post-treatment voice in 81.3% of cases, and CAPE-V scores showed an average reduction of 32.3 points (p < 0.01). There was an average reduction in VHI-10 scores of 11.3 (p = 0.02). The raters perceived the post-AAM treatment videostroboscopy exams to be better in 68.8% of cases. Thirty-seven percent of incomplete glottic closure was considered complete, and there was no change in pliability at 3 months post-AAM injection. CONCLUSIONS: This is the first study on AAM as an injection material in the vocal fold for augmentation laryngoplasty in unilateral vocal fold paralysis. It appears to be safe and effective on early follow-up. Additional studies with longer follow-up are needed.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Santa Maria C, Shuman EA, Bensoussan YE, et al. Prospective Short-Term Outcomes of Allograft Adipose Matrix (AAM) for Vocal Fold Augmentation. Laryngoscope. 2025. PMID: 41195694. doi:10.1002/lary.70240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。